Article
PNPLA3 polymorphisms and risk of hepatic and extrahepatic outcomes in MASLD: A meta-analysis of observational studies.
JHEP reports : innovation in hepatology - 1 Aug 2026
Celsa Ciro, Pennisi Grazia, Tulone Adele, Ciancimino Giacinta, Vaccaro Marco, Pecorella Fabiana, Di Maria Gabriele, Enea Marco, Targher Giovanni, Valenti Luca, Romeo Stefano, Cammà Calogero, Petta Salvatore
Abstract excerpt
BACKGROUND & AIMS: The rs738409C>G polymorphism in the patatin-like phospholipase domain-containing protein 3 gene (PNPLA3 I148M variant) contributes to the largest fraction of metabolic dysfunction-associated steatotic liver disease (MASLD) heritability. However, its prognostic impact on long-term clinical outcomes related to MASLD remains incompletely characterized. We performed a meta-analysis of observational...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
